Intuitive Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
VahatiCor is developing the A-FLUX Reducer System, an interventional device to treat coronary microvascular dysfunction, a condition affecting millions of patients—particularly women—who experience chest pain and cardiac symptoms despite normal standard angiography results.
HardwareHealthtechMedical DevicesSanta Clara, US
Marwan Berrada(Founder and Chairman)inHarry Rowland(CEO)Kevin Van Bladel(Chief Technology Officer)Mark Niggli(Chief Commercial Officer)Marwan Berrada-Sounni(Executive Officer, Director)
BoardBrian R. Smith(Director)in
Co-investorsS3 Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.